Tumour Type: Glioblastoma (GBM)
-
Clinical Trial of Cannabis Derivatives
-
Mapping glioblastoma cells
-
The Brain Tumour Charity Chair of Translational Neuro-oncology
-
Systems approach to therapeutic combinations for glioblastoma
-
Shining a light on the role of lipid metabolism as a barrier to successful brain tumour treatment
-
Engineering cells of the immune system to target the complex mixtures of cells in adult and paediatric gliomas
-
Hijacking an innate immune mechanism present in all malignant cells
-
Uncovering the role of tumour microenvironments in glioblastomas
-
Reprogramming immune cells to increase treatment options for glioma patients
-
Fighting recurrent Glioblastomas with immunotherapy
-
Boosting the immune system to combat glioblastoma
-
Exploring the immune cells in skull bone marrow to treat glioblastoma
-
Using Mini-Brain Models to Study Glioblastoma Treatment Responses
-
Finding New Targets for Glioblastoma Immunotherapy Treatments
-
Identifying unique protein markers in brain tumours to develop new immune-based treatments
-
Using the immune response to target glioblastoma
-
Exploring the use of “smart viruses” to treat glioblastoma
-
Targeting protein kinases to develop effective drugs for glioblastoma
-
Ultrasound-guided, multi-drug delivery for Glioblastoma
-
Preventing Glioblastoma Recurrence Using a Post-surgery Drug Paste
-
Targeting Treatment Resistance in Gliomas to Rapidly Push CAR-T Cell Therapies to Clinic
-
Blocking DNA Repair in Gliomas to Overcome Resistance